Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCESpecialty psychiatry — sexual dysfunction and paraphilias

Psych CASC / OSCE · Specialty psychiatry — sexual dysfunction and paraphilias

Explain antidepressant sexual side-effects and paraphilia thresholds — CASC communication station

MRCPsych/FRANZCP-style communication station: SSRI sexual SE, switch options, and non-pathologising education on paraphilic disorder thresholds.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 33-year-old man whose depression has remitted on escitalopram wants to stop the drug because of delayed ejaculation and low desire. He also nervously asks whether having fetishistic interests with a consenting partner means he is a 'paraphiliac who needs antiandrogens.' Explain medication-related sexual dysfunction options, clarify paraphilia vs disorder, and set a collaborative plan without stigma.

Station brief

Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in the outpatient clinic. [4]

Candidate instructions. Explain that sexual side-effects are common with SSRIs, outline options (continue with monitoring, dose review, switch strategies), warn about depression relapse if stopping abruptly without a plan, and educate that consensual adult fetishistic interest without distress or nonconsent is not a disorder and does not require antiandrogens. Check understanding and agree follow-up. [1][2][3]

Candidate scenario

Depression has been remitted for 4 months on escitalopram 20 mg oral daily. Sexual side-effects began after dose titration and are the main adherence threat. Partner is supportive. Fetishistic interests are adult, consensual, ego-syntonic, and non-impairing. He has been reading alarming online forums about “chemical castration.” [1][3]

Marking domains

  • Empathy, privacy, non-stigmatising language about sex
  • Accurate link between SSRI and desire/orgasm delay
  • Balanced options: do not force stay or abrupt stop
  • Relapse-prevention framing if changing antidepressant
  • Clear paraphilia vs disorder education (distress/impairment/nonconsent)
  • Explicitly reject unnecessary antiandrogens for consensual adult diversity
  • Safety-net for mood deterioration; teach-back [2][3][4]
Reveal assessor key

Open. Thank him for raising an awkward topic; normalise sexual side-effect discussion as part of good antidepressant care. [4]

Explain SE. “Medicines like escitalopram often reduce sexual desire or delay climax because of their serotonin effects — this is a recognised side-effect, not a personal failure and not proof your relationship is the only problem.” [1][2]

Options. Collaborative menu: sometimes waiting if mild; reviewing dose if clinically safe; switching to another antidepressant that is often kinder sexually; never stop suddenly without a plan because depression can return. Agree monitoring of mood and sexual function. [2][4]

Paraphilia education. “Having a fetish with a consenting adult partner, without distress and without anyone being harmed or non-consenting, is not a mental disorder and does not need hormone-blocking treatment. We reserve those specialist medicines for specific high-risk or highly distressing clinical situations under careful supervision.” [3]

Close. Summarise plan, written information if available, crisis contacts if mood drops, book review after any medication change, teach-back. [4]

References

  1. [1]Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients J Clin Psychiatry, 2001.PMID 11229449
  2. [2]Serretti A, Chiesa A Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis J Clin Psychopharmacol, 2009.PMID 19440080
  3. [3]Krueger RB, Reed GM, First MB, et al. Proposals for Paraphilic Disorders in the International Classification of Diseases and Related Health Problems, Eleventh Revision (ICD-11) Arch Sex Behav, 2017.PMID 28210933
  4. [4]Clayton AH, El Haddad S, Iluonakhamhe JP, et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment Expert Opin Drug Saf, 2014.PMID 25148932